🇺🇸 FDA
Patent

US 11680244

Method for generating human dendritic cells for immunotherapy

granted A61KA61K40/19A61K40/24

Quick answer

US patent 11680244 (Method for generating human dendritic cells for immunotherapy) held by The Regents of the University of California expires Mon Jun 15 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jun 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 15 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K40/19, A61K40/24, A61K40/4202